Bolt Biotherapeutics Inc
(BOLT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 14,588 | 9,572 | 10,819 | 9,381 | 10,124 |
| Cost of Goods | 7,816 | 4,912 | 5,564 | 5,046 | 5,482 |
| Gross Profit | 6,772 | 4,660 | 5,255 | 4,335 | 4,642 |
| Operating Expenses | 4,742 | 4,654 | 3,748 | 3,156 | 2,798 |
| Operating Income | 2,846 | 918 | 2,071 | 1,225 | 2,326 |
| Other Income | 41 | 46 | 50 | 65 | 80 |
| Pre-tax Income | 2,887 | 964 | 2,121 | 1,290 | 2,406 |
| Income Tax | 941 | 244 | 735 | 263 | 725 |
| Net Income Continuous | 1,946 | 720 | 1,386 | 1,027 | 1,681 |
| Net Income | $1,946 | $720 | $1,386 | $1,027 | $1,681 |
| EPS Basic Total Ops | 0.23 | 0.08 | 0.16 | 0.12 | 0.20 |
| EPS Basic Continuous Ops | 0.23 | 0.08 | 0.16 | 0.12 | 0.20 |
| EPS Diluted Total Ops | 0.23 | 0.08 | 0.16 | 0.12 | 0.20 |
| EPS Diluted Continuous Ops | 0.23 | 0.08 | 0.16 | 0.12 | 0.20 |
| EBITDA(a) | $3,258 | $1,291 | $2,504 | $1,633 | $2,520 |